When did ARCUTIS BIOTHERAPEUTICS INC (ARQT) report earnings last quarter?
ARCUTIS BIOTHERAPEUTICS INC (ARQT) last reported earnings on 2/25/2026.
ARCUTIS BIOTHERAPEUTICS INC (ARQT) Earnings History & Surprises
NASDAQ:ARQT • US03969K1088
Current stock price
23.655 USD
+0.03 (+0.11%)
At close:
23.655 USD
0 (0%)
After Hours:
ARQT Earnings overview
Past quarterly earnings results for ARCUTIS BIOTHERAPEUTICS INC (ARQT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.06
- Revenue Estimate
- 103.29M
Last Reported
Most Recent- Release Date
- Feb 25, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.13
- EPS Surprise
- 12.39%
- Revenue Surprise
- 12.30%
Beat Rate
Last 8 Quarters 100%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.13 | 0.12 | 12.39% | 244.44% | 129.503M | 115.32M | 12.30% | 81.48% |
| Q3 2025 | 0.06 | -0.10 | 158.91% | 118.18% | 99.219M | 88.718M | 11.84% | 121.69% |
| Q2 2025 | -0.13 | -0.16 | 19.41% | 69.05% | 81.504M | 75.162M | 8.44% | 164.13% |
| Q1 2025 | -0.20 | -0.21 | 6.63% | 37.50% | 65.846M | 63.495M | 3.70% | 32.84% |
| Q4 2024 | -0.09 | -0.26 | 65.40% | 87.50% | 71.36M | 61.363M | 16.29% | 427.58% |
| Q3 2024 | -0.33 | -0.43 | 22.44% | 54.79% | 44.755M | 38.369M | 16.64% | 17.44% |
| Q2 2024 | -0.42 | -0.53 | 20.28% | 63.79% | 30.858M | 29.662M | 4.03% | 494.57% |
| Q1 2024 | -0.32 | -0.74 | 57.02% | 75.57% | 49.569M | 14.974M | 231.03% | 1,682.42% |
| Q4 2023 | -0.72 | -0.79 | 8.92% | 38.98% | 13.526M | 11.567M | 16.94% | 356.96% |
| Q3 2023 | -0.73 | -0.87 | 16.54% | 61.38% | 38.109M | 33.485M | 13.81% | 5,120.41% |
| Q2 2023 | -1.16 | -1.28 | 9.03% | 11.45% | 5.19M | 4.692M | 10.61% | - |
| Q1 2023 | -1.31 | -1.31 | 0.03% | -3.15% | 2.781M | 3.2M | -13.09% | - |
| Q4 2022 | -1.18 | -1.45 | 18.71% | 16.90% | 2.96M | 2.247M | 31.73% | - |
| Q3 2022 | -1.89 | -1.70 | -11.03% | -65.79% | 730K | 663K | 10.11% | - |
| Q2 2022 | -1.31 | -1.46 | 10.40% | -55.95% | - | - | ||
| Q1 2022 | -1.27 | -1.53 | 17.10% | -67.11% | - | - | ||
| Q4 2021 | -1.42 | -1.52 | 6.88% | -79.75% | - | - | ||
| Q3 2021 | -1.14 | -1.17 | 2.95% | -12.87% | - | - | ||
| Q2 2021 | -0.84 | -0.92 | 8.67% | 10.64% | - | - | ||
| Q1 2021 | -0.76 | -0.98 | 22.18% | 33.91% | - | - | ||
| Q4 2020 | -0.79 | -0.90 | 11.99% | - | - | - | ||
| Q3 2020 | -1.01 | -0.92 | -9.72% | - | - | - | ||
| Q2 2020 | -0.94 | -0.86 | -9.28% | - | - | - | ||
| Q1 2020 | -1.15 | -0.94 | -22.99% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
49.33%
Max EPS beat (4)
158.91%
Min EPS beat (4)
6.63%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
9.07%
Max Revenue beat (4)
12.30%
Min Revenue beat (4)
3.70%
Analysis
In the last 4 quarters, ARQT has consistently beaten EPS estimates in all releases
ARQT has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ARQT has beaten the EPS estimates by 49.3% on average.
In the last 4 quarters, ARQT has beaten the revenue estimates by 9.1% on average.
Related analysis
ARCUTIS BIOTHERAPEUTICS INC / ARQT Earnings FAQ
Did ARQT stock beat earnings estimates in the most recent quarter?
ARCUTIS BIOTHERAPEUTICS INC (ARQT) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does ARCUTIS BIOTHERAPEUTICS INC (ARQT) beat earnings estimates?
In the last 4 quarters, ARCUTIS BIOTHERAPEUTICS INC (ARQT) has beaten EPS estimates in 4 out of 4 releases.